	Platelet-Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities. Discov Oncol Mariani V, Lee NH. PMID: 42319679 [PubMed - as supplied by publisher]
	Anatomy and patient comorbidity in robotic partial nephrectomy: predictors of complexity and outcomes. J Robot Surg Pumfrey N, Azhar F, Harwood R, Rahemtoola MS, Zelhof B. PMID: 42319664 [PubMed - indexed for MEDLINE]
	Digital twin technologies in prostate cancer as a frontier for precision medicine. Eur Radiol Exp Pecoraro M, Messina E, Novelli S, Laschena L, Blasilli G, Tronci E, Panebianco V. PMID: 42319650 [PubMed - indexed for MEDLINE]
	Integrative analysis of the roles and prognostic value of RNA-binding proteins in papillary renal cell carcinoma. Discov Oncol Niu T, Li Q, Zhang A. PMID: 42319639 [PubMed - as supplied by publisher]
	Tumor anatomy predictors of mic and trifecta achievement in robot-assisted partial nephrectomy: a multicenter analysis stratified by PADUA score. J Robot Surg Kanaan MR, Idais H, Faraj Tabrizi P, Schiefelbein F, Schoen G, Wiesinger C, Ubrig B, Gloger S, Nuhn P, Eraky A, Wagner C, Ayanle A, Al-Nader M, Hadaschik BA, Münden JF, Katzendorn O, Fuhrmann C, Kuczyk MA, Siemer S, Zeuschner P, Mayr R, Harke NN. PMID: 42319570 [PubMed - indexed for MEDLINE]
	Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation. Abdom Radiol (NY) Arita Y, Zheng X, Wen F, Fujiwara M, Bijari M, Glaudemans AWJM, Ruiter SJS, Lütje S, Noordzij W. PMID: 42319425 [PubMed - as supplied by publisher]
	Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib. Cancer McKay RR, Xie W, Ajmera A, Araneta A, Folefac E, Hussain A, Kyriakopoulos CE, Olson A, Parikh M, Parikh R, Saraiya B, Shapiro GI. PMID: 42319132 [PubMed - indexed for MEDLINE]
	Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial. Cancer Cheng Y, Huang H, Wang M, Zhu L, Peng S, Li D, Marra G, Qi R, Ding X, Liu M, Qiu X, Guo H. PMID: 42319125 [PubMed - indexed for MEDLINE]
	Primary testicular neuroendocrine tumor: Diagnostic challenges and WHO 2022 classification insights. J Int Med Res Garousi V, Khalaj F, Mirzaian E. PMID: 42319038 [PubMed - indexed for MEDLINE]
	Diagnostic performance of biparametric versus multiparametric MRI for prostate cancer: a noninferiority, confirmatory observer study. Front Oncol Fang X, Li J, Lv W, Liu L, Feng J, Liu L, Pan F, Zhang Y. PMID: 42318473 [PubMed]
	Genetic insights revealed ADRB1 as potential target for clear cell renal cell carcinoma. Front Pharmacol Zhu H, Lin Q, Yu Z, Huang X. PMID: 42318352 [PubMed]
	Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study. Mil Med Res He YB, Hu J, Liu Z, Xiao ZC, Liu JH, Liang HS, Deng WZ, Li ZW, Zhang J, Long JQ, Gao N, Huang B, Guo X, Ou ZY, Chen JB, Liu PH, Chen MF, Li HH, Wang RZ, Guan X, Tong SY, Li YL, He W, Zhao YH, Cai ZY, Gan Y, Zhao C, Cui Y, Dai YQ, Cai Y, Nie ZY, Zhou WM, Zhou BH, Hu MH, Fan BY, Deng DS, Zu XB. PMID: 42318044 [PubMed - indexed for MEDLINE]
	A diagnostic signature derived from NK cell related genes in prostate cancer: insights from integrated scRNA-seq and bulk RNA-seq analyses with functional validation of KIT. Front Immunol Chen Z, Zhou F, Tian J, Lv Q, Wang D, Fan S. PMID: 42317356 [PubMed - indexed for MEDLINE]
	Structured micro-ultrasonography training improves prostate cancer detection and management decisions. BJU Int Wessendorf MP, Mangold MH, Baumann G, Winter N, Braun JJ, Lehmberg J, Studier-Fischer A, Brochhausen C, Michel MS, Carlsson SV, Kowalewski KF, Haney-Aubert CM. PMID: 42316473 [PubMed - as supplied by publisher]
	The glycobiology of prostate cancer: an update. Oncogene Hodgson K, Orozco-Moreno M, Peng Z, Blencoe L, Sharp MJ, Smith E, Grimsley G, Elliott DJ, Beatson R, Drake RR, Munkley J. PMID: 42315913 [PubMed - as supplied by publisher]
	LINC00222 regulates FOXO3 to interfere with Î²-catenin signaling pathway and suppresses prostate cancer progression. Sci Rep Li H, Zhao W, Deng Y, Liu Z, Li J, Tian S. PMID: 42315881 [PubMed - as supplied by publisher]
	Lutetium-177-PSMA I&T (Lu-PSMA) with radiosensitising capecitabine in patients with metastatic castration-resistant prostate cancer (mCRPC): results of phase Ia study. Eur J Nucl Med Mol Imaging Leslie C, Al-Ogaili Z, Oh L, Slattery T, Shaji S, Marsavela G, Mills A, Stone C, Ferguson T. PMID: 42315637 [PubMed - as supplied by publisher]
	The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of hormone-sensitive prostate cancer - study protocol. BMJ Open van der Gaag S, Vis A, Bartelink I, Hendrikse H, Oprea-Lager DE. PMID: 42315278 [PubMed - indexed for MEDLINE]
	Retzius-Sparing Laparoscopic Radical Prostatectomy in A Nonrobotic Setting: A 30-Case Implementation Series With Minimum 18-Month Follow-Up. Asian J Endosc Surg Fernandez-Alberti J, Ernst G, Scolari G, Lopez AV, Panzardi N, Featherston M, Martinez PM. PMID: 42315251 [PubMed - indexed for MEDLINE]
	Elevated allostatic load, adverse body composition, and reduced overall survival in a retrospective cohort of men with newly diagnosed metastatic prostate cancer. J Acad Nutr Diet Sheean PM, O'Connor P, Bolouri M, Wozniak A, Joyce C, Vasilopoulos V, Badami A. PMID: 42314899 [PubMed - as supplied by publisher]

Articles 1 - 20 / 179120

Page 1 of 8956



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy